TIMI, GRACE and alternative risk scores in Acute Coronary Syndromes: a meta-analysis of 40 derivation studies on 216,552 patients and of 42 validation studies on 31,625 patients.
about
Risk stratification in non-ST elevation acute coronary syndromes: Risk scores, biomarkers and clinical judgmentClinical assessment of patients with chest pain; a systematic review of predictive toolsRisk stratification for ST segment elevation myocardial infarction in the era of primary percutaneous coronary intervention.Dickkopf-1 as a novel predictor is associated with risk stratification by GRACE risk scores for predictive value in patients with acute coronary syndrome: a retrospective researchRenal dysfunction in STEMI-patients undergoing primary angioplasty: higher prevalence but equal prognostic impact in female patients; an observational cohort study from the Belgian STEMI registry.Risk stratification and prognostic value of grace and timi risk scores for female patients with non-st segment elevation acute coronary syndrome.Artificial neural network modeling using clinical and knowledge independent variables predicts salt intake reduction behavior.The relationship between neutrophil to lymphocyte ratio, platelet to lymphocyte ratio and thrombolysis in myocardial infarction risk score in patients with ST elevation acute myocardial infarction before primary coronary intervention.Validation study of GRACE risk scores in indigenous and non-indigenous patients hospitalized with acute coronary syndrome.The prognostic utility of GRACE risk score in predictive cardiovascular event rate in STEMI patients with successful fibrinolysis and delay intervention in non PCI-capable hospital: a retrospective cohort studyN-terminal pro-brain natriuretic peptide improves the C-ACS risk score prediction of clinical outcomes in patients with ST-elevation myocardial infarction.Accuracy of bleeding scores for patients presenting with myocardial infarction: a meta-analysis of 9 studies and 13 759 patientsRegression trees for predicting mortality in patients with cardiovascular disease: what improvement is achieved by using ensemble-based methods?Impact of Admission Glycosylated Hemoglobin A1c on Angiographic Characteristics and Short Term Clinical Outcomes of Nondiabetic Patients with Acute ST-Segment Elevation Myocardial Infarction.Canada acute coronary syndrome score was a stronger baseline predictor than age ≥75 years of in-hospital mortality in acute coronary syndrome patients in western Romania.Developing points-based risk-scoring systems in the presence of competing risks.Medical emergencies: atrial fibrillation and myocardial infarction.Selection and timing for invasive therapy in non-ST-segment-elevation acute coronary syndrome.Discontinuation of dual antiplatelet therapy over 12 months after acute coronary syndromes increases risk for adverse events in patients treated with percutaneous coronary intervention: systematic review and meta-analysis.Risk Scores After Acute Coronary Syndrome.Predictive values of D-dimer assay, GRACE scores and TIMI scores for adverse outcome in patients with non-ST-segment elevation myocardial infarction.Review article: Diagnostic accuracy of risk stratification tools for patients with chest pain in the rural emergency department: A systematic review.Risk stratification after ST-segment elevation myocardial infarction.The Prognostic Value of Heart Type Fatty Acid Binding Protein in Patients with Suspected Acute Coronary Syndrome: A Systematic Review.Validation of the Canada Acute Coronary Syndrome Risk Score for Hospital Mortality in the Gulf Registry of Acute Coronary Events-2.Clinical presentation, management, in-hospital and 90-day outcomes of heart failure patients in Trivandrum, Kerala, India: the Trivandrum Heart Failure Registry.Acute Coronary Syndrome Screening and Diagnostic Practice Variation.Additive prognostic value of left ventricular ejection fraction to the TIMI risk score for in-hospital and long-term mortality in patients with ST segment elevation myocardial infarction.White Blood Cell Subtypes Are Associated with a Greater Long-Term Risk of Death after Acute Myocardial Infarction.ACTION (acute coronary treatment and intervention outcomes network) registry-GWTG (get with the guidelines) risk score predicts long-term mortality in acute myocardial infarction.THE STORM (acute coronary Syndrome in paTients end Of life and Risk assesMent) study.Prognostic value of admission glycated haemoglobin in unknown diabetic patients with acute myocardial infarction.Prognostic value of blood count parameters in patients with acute coronary syndrome.Coronary computed tomographic angiography for detection of coronary artery disease in patients presenting to the emergency department with chest pain: a meta-analysis of randomized clinical trials.Long-Term Prognostic Implications of the Admission Shock Index in Patients With Acute Myocardial Infarction Who Received Percutaneous Coronary Intervention.Copeptin as a Prognostic Marker in Acute Chest Pain and Suspected Acute Coronary Syndrome.
P2860
Q26769732-A35339CC-B33E-4D50-BF14-56AD76129C05Q28070000-569BA466-6164-45D6-8EFB-8E5B998047E9Q34179101-285836AD-F66A-437D-B30F-046188FFDC88Q34566162-A68B6E6D-B466-448D-8D64-E60AF3A09272Q34626258-B2F80B57-82D3-4462-86F5-A2EC6FC238B5Q35643862-48963316-AF60-4B19-9DE3-29039B56120BQ35671801-801B41A3-3C20-4078-B3EA-6ECDD879AEB5Q35829164-BA2DBB31-2EBC-4935-A302-CB71C1724FEEQ35843015-94D5A700-D7B6-4398-BDF3-DA5120DEF9EFQ36184563-FE990AB6-3E04-4AF1-AFD8-90B1B7F96498Q36220719-F87A9CFA-794B-4EB6-90A2-5CA11237213EQ36245033-5C8C33AD-1B94-4D53-B725-8D2583521D18Q36315061-291D312A-B828-4F76-A2EC-1879D1297A1BQ36368989-F4FBD5EE-7E8D-4274-872A-6D47DC4212D6Q36857842-AD936805-8890-479F-B67D-41E137D85E31Q37375552-80176CA3-B36C-47EA-8065-CB546B4C6671Q38064908-81270A1E-CC76-4D6F-A6D1-347488750270Q38097508-157D35A5-14B0-47C7-A8A7-0CA6B51673CAQ38195850-219B262E-A205-4E41-AF37-3B4AA7DBDFDFQ38835473-1007602D-92B7-4392-92BC-C23058723B85Q38837498-A77C2EA8-660E-4859-8548-CDC2CFEAE3C6Q38911741-C2F43FD6-F032-4961-AF4E-0CC96BEC2E9DQ39000195-7F0CD547-B140-488C-B588-20AE4474056EQ39017422-A62F2CA6-B08D-4D03-98F8-B3ECB32615DFQ39199551-4B01171A-BE7B-4610-9EE9-410971D7DF61Q40283235-4D05B72E-713F-435F-A3DB-0D69174F290FQ40307287-623DB340-69C9-49F4-B8F9-15D083CA756EQ40630818-54A1082F-A465-475B-8D80-A54EF7FDD1BBQ40982358-CA4AFBB2-10D2-4BCB-B387-9D700F4FD28FQ47111055-5DB3E4F8-D586-4BAD-9368-4D5C04D7539FQ48039376-88BCC619-05A7-41A8-BB54-514B5894C5F7Q51745510-2B2D2CEA-EC11-4768-A6BB-47BBF0B99E15Q52714979-C3B0CC00-DE28-40C2-A9E6-E09E4BC9F94CQ53129467-D714E20B-955C-4A03-8C7E-21C7D11AF6EDQ54190029-8CE669F3-22F6-4875-8ADC-DC33C3A9387FQ55002418-0399C743-E6B0-412D-99E4-8465E15CD2CC
P2860
TIMI, GRACE and alternative risk scores in Acute Coronary Syndromes: a meta-analysis of 40 derivation studies on 216,552 patients and of 42 validation studies on 31,625 patients.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
TIMI, GRACE and alternative ri ...... on studies on 31,625 patients.
@en
TIMI, GRACE and alternative ri ...... on studies on 31,625 patients.
@nl
type
label
TIMI, GRACE and alternative ri ...... on studies on 31,625 patients.
@en
TIMI, GRACE and alternative ri ...... on studies on 31,625 patients.
@nl
prefLabel
TIMI, GRACE and alternative ri ...... on studies on 31,625 patients.
@en
TIMI, GRACE and alternative ri ...... on studies on 31,625 patients.
@nl
P2093
P50
P1476
TIMI, GRACE and alternative ri ...... on studies on 31,625 patients.
@en
P2093
Davide G Presutti
Fabrizio D'Ascenzo
Filippo Sciuto
Fiorenzo Gaita
Imad Sheiban
Mario Bollati
Pierluigi Omedè
P304
P356
10.1016/J.CCT.2012.01.001
P407
P577
2012-01-11T00:00:00Z